|
1
|
Jambo KC, Sepako E, Fullerton DG, Mzinza
D, Glennie S, Wright AK, Heyderman RS and Gordon SB:
Bronchoalveolar CD4+ T cell responses to respiratory
antigens are impaired in HIV-infected adults. Thorax. 66:375–382.
2011.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Härter G, Spinner CD, Roider J, Bickel M,
Krznaric I, Grunwald S, Schabaz F, Gillor D, Postel N, Mueller MC,
et al: COVID-19 in people living with human immunodeficiency virus:
A case series of 33 patients. Infection. 48:681–686.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hussain N, Yoganathan A, Hewage S, Alom S
and Harky A: The effect of antivirals on COVID-19: A systematic
review. Expert Rev Anti Infect Ther: Oct 20, 2020 (Epub ahead of
print).
|
|
4
|
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang
H, Wang T, Zhang X, Chen H, Yu H, et al: Clinical and immunological
features of severe and moderate coronavirus disease 2019. J Clin
Invest. 130:2620–2629. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Branco ACCC, Sato MN and Alberca RW: The
possible dual role of the ACE2 receptor in asthma and coronavirus
(SARS-CoV2) infection. Front Cell Infect Microbiol.
10(550571)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Alberca RW, Pereira NZ, Oliveira LMDS,
Gozzi-Silva SC and Sato MN: Pregnancy, viral infection, and
COVID-19. Front Immunol. 11(1672)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Alberca RW: Asthma endotypes and COVID-19.
J Asthma: Oct 1, 2020 (Epub ahead of print).
|
|
8
|
Mirzaei H, McFarland W, Karamouzian M and
Sharifi H: COVID-19 among people living with HIV: a systematic
review. AIDS Behav: Jul 30, 2020 (Epub ahead of print).
|
|
9
|
Alberca RW, Yendo TM, Leuzzi Ramos YÁ,
Fernandes IG, Oliveira LM, Teixeira FME, Beserra DR, de Oliveira
EA, Gozzi-Silva SC, Andrade MMS, et al: Case report: COVID-19 and
Chagas disease in Two coinfected patients. Am J Trop Med Hyg: Oct
6, 2020 (Epub ahead of print).
|
|
10
|
Marino A, Pampaloni A, Scuderi D,
Cosentino F, Moscatt V, Ceccarelli M, Gussio M, Celesia BM, Bruno
R, Borraccino S, Borraccino S, et al: High-flow nasal cannula
oxygenation and tocilizumab administration in patients critically
ill with COVID-19: A report of three cases and a literature review.
World Acad Sci J. 2(23)2020.
|
|
11
|
Chen H, Zhang L, He Z, Wang D, Liu L,
Xhang W, Chen T, Dai Z, Han Z and Chen M: Systemic administration
of human umbilical cord-derived mesenchymal stem cells effectively
ameliorates the outcomes of a critically ill elderly patient with
COVID-19 with multiple comorbidities: A case report. World Acad Sci
J. 2(29)2020.
|
|
12
|
Alberca RW, Teixeira FME, Beserra DR, de
Oliveira EA, Andrade MMS, Pietrobon AJ and Sato MN: Perspective:
The Potential Effects of Naringenin in COVID-19. Front Immunol.
11(570919)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Liu Y, Du X, Chen J, Jin Y, Peng L, Wang
HHX, Luo M, Chen L and Zhao Y: Neutrophil-to-lymphocyte ratio as an
independent risk factor for mortality in hospitalized patients with
COVID-19. J Infect. 81:e6–e12. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Alberca RW, Andrade MMS, Branco ACCC,
Pietrobon AJ, Pereira NZ, Fernandes IG, Oliveira LM, Teixeira FME,
Beserra DR, de Oliveira EA, et al: Frequencies of CD33+CD11b+
HLA-DR-CD14-CD66b+ and CD33+CD11b+HLA-DR-CD14+ CD66b- cells in
peripheral blood as severity immune biomarkers in COVID-19. Front
Med (Lausanne). 7(580677)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
de la Rica R, Borges M, Aranda M, Del
Castillo A, Socias A, Payeras A, Rialp G, Socias L, Masmiquel L and
Gonzalez-Freire M: Low albumin levels are associated with poorer
outcomes in a case series of COVID-19 patients in Spain: a
retrospective cohort study. Microorganisms. 8(1106)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Codo AC, Davanzo GG, Monteiro LB, de Souza
GF, Muraro SP, Virgilio-da-Silva JV, Prodonoff JS, Carregari VC, de
Biagi Junior CAO, Crunfli F, et al: Elevated glucose levels favor
SARS-CoV-2 infection and monocyte response through a
HIF-1α/glycolysis dependent axis. Cell Metab. 32:498–499.
2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi
Y, Sun R, Tian Z, Xu X and Wei H: Pathogenic T cells and
inflammatory monocytes incite inflammatory storm in severe COVID-19
patients. Natl Sci Rev. 7:998–1002. 2020.
|
|
18
|
Liu F, Xu A, Zhang Y, Xuan W, Yan T, Pan
K, Yu W and Zhang J: Patients of COVID-19 may benefit from
sustained Lopinavir-combined regimen and the increase of Eosinophil
may predict the outcome of COVID-19 progression. Int J Infect Dis.
95:183–191. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang M, Luo L, Bu H and Xia H: One case of
coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV
with a low CD4+ T-cell count. Int J Infect Dis. 96:148–150.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Vizcarra P, Pérez-Elías MJ, Quereda C,
Moreno A, Vivancos MJ, Dronda F, Casado JL, Moreno S, Pérez-Elías
MJ, Fortún J, et al: COVID-19 ID Team: Description of COVID-19 in
HIV-infected individuals: A single-centre, prospective cohort.
Lancet HIV. 7:e554–e564. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Agarwal N, Iyer D, Gabbi C, Saha P, Patel
SG, Mo Q, Chang B, Goswami B, Schubert U, Kopp JB, et al: HIV-1
viral protein R (Vpr) induces fatty liver in mice via LXRα and
PPARα dysregulation: Implications for HIV-specific pathogenesis of
NAFLD. Sci Rep. 7(7)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wanjalla CN, McDonnell WJ and Koethe JR:
Adipose tissue T Cells in HIV/SIV infection. Front Immunol.
9(2730)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Alberca RW, Oliveira LM, Branco ACCC,
Pereira NZ and Sato MN: Obesity as a risk factor for COVID-19: An
overview. Crit Rev Food Sci Nutr: Jun 15, 2020 (Epub ahead of
print).
|
|
24
|
Lukic L, Lalic NM, Rajkovic N, Jotic A,
Lalic K, Milicic T, Seferovic JP, Macesic M and Gajovic JS:
Hypertension in obese type 2 diabetes patients is associated with
increases in insulin resistance and IL-6 cytokine levels: Potential
targets for an efficient preventive intervention. Int J Environ Res
Public Health. 11:3586–3598. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gervasoni C, Meraviglia P, Riva A,
Giacomelli A, Oreni L, Minisci D, Atzori C, Ridolfo A and Cattaneo
D: Clinical features and outcomes of patients with human
immunodeficiency virus with COVID-19. Clin Infect Dis.
71:2276–2278. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Cooper TJ, Woodward BL, Alom S and Harky
A: Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS
patients: A systematic review. HIV Med. 21:567–577. 2020.PubMed/NCBI View Article : Google Scholar
|
